fanta.bio Sample: CNhs10616
17917 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| HIF1A SRX11007095 | HK-2 Kidney | 2349 / 17544 (13.4%) | 898 / 175440 (0.5%) | −324.0 | −324.0 | 26.16 |
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1075 / 17544 (6.1%) | 491 / 175440 (0.3%) | −324.0 | −324.0 | 21.89 |
| HIF1A SRX20663235 | HK-2 Kidney | 542 / 17544 (3.1%) | 266 / 175440 (0.2%) | −324.0 | −324.0 | 20.38 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1545 / 17544 (8.8%) | 853 / 175440 (0.5%) | −324.0 | −324.0 | 18.11 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1549 / 17544 (8.8%) | 876 / 175440 (0.5%) | −324.0 | −324.0 | 17.68 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2237 / 17544 (12.8%) | 1289 / 175440 (0.7%) | −324.0 | −324.0 | 17.35 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2171 / 17544 (12.4%) | 1251 / 175440 (0.7%) | −324.0 | −324.0 | 17.35 |
| SCML2 SRX644728 | 293 Kidney | 1279 / 17544 (7.3%) | 823 / 175440 (0.5%) | −324.0 | −324.0 | 15.54 |
| BRD4 SRX9419935 | BT-474 Breast | 3779 / 17544 (21.5%) | 2907 / 175440 (1.7%) | −324.0 | −324.0 | 13.00 |
| MED1 SRX9419945 | BT-474 Breast | 3775 / 17544 (21.5%) | 2911 / 175440 (1.7%) | −324.0 | −324.0 | 12.97 |
| MED1 SRX9419944 | BT-474 Breast | 3670 / 17544 (20.9%) | 2880 / 175440 (1.6%) | −324.0 | −324.0 | 12.74 |
| BRD4 SRX9419936 | BT-474 Breast | 3829 / 17544 (21.8%) | 3053 / 175440 (1.7%) | −324.0 | −324.0 | 12.54 |
| BRD4 SRX9419938 | BT-474 Breast | 3797 / 17544 (21.6%) | 3063 / 175440 (1.7%) | −324.0 | −324.0 | 12.40 |
| MED1 SRX9419946 | BT-474 Breast | 3815 / 17544 (21.7%) | 3086 / 175440 (1.8%) | −324.0 | −324.0 | 12.36 |
| BRD4 SRX9419937 | BT-474 Breast | 3703 / 17544 (21.1%) | 3030 / 175440 (1.7%) | −324.0 | −324.0 | 12.22 |
| FOXP1 SRX736067 | LNCAP Prostate | 1622 / 17544 (9.2%) | 1341 / 175440 (0.8%) | −324.0 | −324.0 | 12.10 |
| MED1 SRX9419947 | BT-474 Breast | 3681 / 17544 (21.0%) | 3064 / 175440 (1.7%) | −324.0 | −324.0 | 12.01 |
| MYH11 SRX265221 | ME-1 Blood | 805 / 17544 (4.6%) | 696 / 175440 (0.4%) | −324.0 | −324.0 | 11.57 |
| EZH2 SRX2146136 | LNCAP Prostate | 7845 / 17544 (44.7%) | 8587 / 175440 (4.9%) | −324.0 | −324.0 | 9.14 |
| BRD4 SRX736201 | 90-8TL Neural | 5640 / 17544 (32.1%) | 7102 / 175440 (4.0%) | −324.0 | −324.0 | 7.94 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1799 / 17544 (10.3%) | 2868 / 175440 (1.6%) | −324.0 | −324.0 | 6.27 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 2075 / 17544 (11.8%) | 5082 / 175440 (2.9%) | −324.0 | −324.0 | 4.08 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1535 / 17544 (8.7%) | 3833 / 175440 (2.2%) | −324.0 | −324.0 | 4.00 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1843 / 17544 (10.5%) | 5462 / 175440 (3.1%) | −324.0 | −324.0 | 3.37 |
| AGO2 SRX4708039 | Hep G2 Liver | 2246 / 17544 (12.8%) | 7741 / 175440 (4.4%) | −324.0 | −324.0 | 2.90 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 2164 / 17544 (12.3%) | 7964 / 175440 (4.5%) | −324.0 | −324.0 | 2.72 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2625 / 17544 (15.0%) | 9898 / 175440 (5.6%) | −324.0 | −324.0 | 2.65 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 2375 / 17544 (13.5%) | 9256 / 175440 (5.3%) | −324.0 | −324.0 | 2.57 |
| RUNX1 SRX2513054 | 293 Kidney | 3996 / 17544 (22.8%) | 18157 / 175440 (10.3%) | −324.0 | −324.0 | 2.20 |
| TRP47 SRX4548329 | THP-1 Blood | 3110 / 17544 (17.7%) | 14226 / 175440 (8.1%) | −324.0 | −324.0 | 2.19 |
| 5-mC SRX882970 | LNCAP Prostate | 3399 / 17544 (19.4%) | 15596 / 175440 (8.9%) | −324.0 | −324.0 | 2.18 |
| 5-mC SRX882968 | LNCAP Prostate | 3325 / 17544 (19.0%) | 15504 / 175440 (8.8%) | −324.0 | −324.0 | 2.14 |
| CIC SRX13262055 | Astrocytes Neural | 3596 / 17544 (20.5%) | 17156 / 175440 (9.8%) | −324.0 | −324.0 | 2.10 |
| PBX4 SRX2731658 | PC-3 Prostate | 842 / 17544 (4.8%) | 27691 / 175440 (15.8%) | −324.0 | −324.0 | 0.30 |
| FOS SRX150478 | MCF 10A Breast | 615 / 17544 (3.5%) | 21178 / 175440 (12.1%) | −324.0 | −324.0 | 0.29 |
| FOS SRX150477 | MCF 10A Breast | 570 / 17544 (3.2%) | 20654 / 175440 (11.8%) | −324.0 | −324.0 | 0.28 |
| YAP1 SRX757325 | H2052 Lung | 532 / 17544 (3.0%) | 21542 / 175440 (12.3%) | −324.0 | −324.0 | 0.25 |
| YAP1 SRX757326 | H2052 Lung | 432 / 17544 (2.5%) | 19226 / 175440 (11.0%) | −324.0 | −324.0 | 0.22 |
| SREBF2 SRX5359048 | HCC70 Breast | 2122 / 17544 (12.1%) | 7751 / 175440 (4.4%) | −323.0 | −320.1 | 2.74 |
| 5-mC SRX882965 | LNCAP Prostate | 2740 / 17544 (15.6%) | 12091 / 175440 (6.9%) | −302.8 | −299.9 | 2.27 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 2323 / 17544 (13.2%) | 9471 / 175440 (5.4%) | −294.7 | −291.8 | 2.45 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 724 / 17544 (4.1%) | 995 / 175440 (0.6%) | −293.1 | −290.2 | 7.28 |
| FOS SRX4192880 | MCF 10A Breast | 428 / 17544 (2.4%) | 16843 / 175440 (9.6%) | −292.4 | −289.6 | 0.25 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 2189 / 17544 (12.5%) | 8734 / 175440 (5.0%) | −287.4 | −284.5 | 2.51 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1920 / 17544 (10.9%) | 7086 / 175440 (4.0%) | −285.6 | −282.7 | 2.71 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 704 / 17544 (4.0%) | 984 / 175440 (0.6%) | −281.7 | −278.8 | 7.15 |
| PTEN SRX5416007 | SMMC-7721 Liver | 2155 / 17544 (12.3%) | 8644 / 175440 (4.9%) | −279.9 | −277.0 | 2.49 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 2134 / 17544 (12.2%) | 8622 / 175440 (4.9%) | −273.4 | −270.6 | 2.48 |
| CDYL2 SRX8321653 | MCF-7 Breast | 2168 / 17544 (12.4%) | 8843 / 175440 (5.0%) | −273.3 | −270.5 | 2.45 |
| MECOM SRX23677896 | HNT-34 Blood | 2499 / 17544 (14.2%) | 11043 / 175440 (6.3%) | −273.0 | −270.1 | 2.26 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1009 / 17544 (5.8%) | 25391 / 175440 (14.5%) | −272.7 | −269.9 | 0.40 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1952 / 17544 (11.1%) | 7490 / 175440 (4.3%) | −272.3 | −269.5 | 2.61 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 2063 / 17544 (11.8%) | 8194 / 175440 (4.7%) | −272.0 | −269.2 | 2.52 |
| RUNX1 SRX2014504 | Jurkat Blood | 2808 / 17544 (16.0%) | 13202 / 175440 (7.5%) | −271.7 | −269.0 | 2.13 |
| MECOM SRX23677897 | HNT-34 Blood | 2416 / 17544 (13.8%) | 10518 / 175440 (6.0%) | −271.2 | −268.4 | 2.30 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 683 / 17544 (3.9%) | 978 / 175440 (0.6%) | −268.7 | −266.0 | 6.98 |
| BMI1 SRX7196721 | SF8628 Neural | 2029 / 17544 (11.6%) | 8061 / 175440 (4.6%) | −267.1 | −264.4 | 2.52 |
| JUN SRX17561461 | LPS141 Adipocyte | 377 / 17544 (2.1%) | 15128 / 175440 (8.6%) | −265.3 | −262.5 | 0.25 |
| TP53 SRX19538279 | Osteoblasts Bone | 457 / 17544 (2.6%) | 318 / 175440 (0.2%) | −264.8 | −262.0 | 14.37 |
| AGO2 SRX6783957 | Hep G2 Liver | 1457 / 17544 (8.3%) | 4702 / 175440 (2.7%) | −261.8 | −259.1 | 3.10 |
| MECOM SRX23677885 | HNT-34 Blood | 2067 / 17544 (11.8%) | 8411 / 175440 (4.8%) | −260.9 | −258.2 | 2.46 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1028 / 17544 (5.9%) | 25198 / 175440 (14.4%) | −259.4 | −256.7 | 0.41 |
| AGO2 SRX6783958 | Hep G2 Liver | 1426 / 17544 (8.1%) | 4580 / 175440 (2.6%) | −257.8 | −255.0 | 3.11 |
| MECOM SRX23677884 | HNT-34 Blood | 2034 / 17544 (11.6%) | 8283 / 175440 (4.7%) | −256.0 | −253.3 | 2.46 |
| RORC SRX5359052 | HCC70 Breast | 1551 / 17544 (8.8%) | 5362 / 175440 (3.1%) | −252.8 | −250.1 | 2.89 |
| FOS SRX150517 | MCF 10A Breast | 502 / 17544 (2.9%) | 16785 / 175440 (9.6%) | −249.3 | −246.6 | 0.30 |
| Epitope tags SRX10549776 | K-562 Blood | 1551 / 17544 (8.8%) | 5413 / 175440 (3.1%) | −249.2 | −246.5 | 2.87 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 729 / 17544 (4.2%) | 20375 / 175440 (11.6%) | −248.4 | −245.7 | 0.36 |
| MITF SRX1555436 | 501A Epidermis | 2234 / 17544 (12.7%) | 9760 / 175440 (5.6%) | −247.2 | −244.5 | 2.29 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 670 / 17544 (3.8%) | 19368 / 175440 (11.0%) | −245.6 | −242.9 | 0.35 |
| TP53 SRX19538274 | U2OS Bone | 378 / 17544 (2.2%) | 206 / 175440 (0.1%) | −240.4 | −237.8 | 18.35 |
| ERG SRX063922 | K-562 Blood | 1808 / 17544 (10.3%) | 7156 / 175440 (4.1%) | −237.8 | −235.1 | 2.53 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1033 / 17544 (5.9%) | 24448 / 175440 (13.9%) | −236.9 | −234.2 | 0.42 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 2150 / 17544 (12.3%) | 9427 / 175440 (5.4%) | −235.6 | −233.0 | 2.28 |
| TP53 SRX19538268 | U2OS Bone | 372 / 17544 (2.1%) | 209 / 175440 (0.1%) | −234.0 | −231.4 | 17.80 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 670 / 17544 (3.8%) | 18900 / 175440 (10.8%) | −231.8 | −229.1 | 0.35 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 2332 / 17544 (13.3%) | 10771 / 175440 (6.1%) | −230.5 | −227.9 | 2.17 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 537 / 17544 (3.1%) | 674 / 175440 (0.4%) | −230.0 | −227.4 | 7.97 |
| RORC SRX5359053 | HCC70 Breast | 1462 / 17544 (8.3%) | 5163 / 175440 (2.9%) | −230.0 | −227.3 | 2.83 |
| IRF3 SRX11453858 | Hep G2 Liver | 298 / 17544 (1.7%) | 82 / 175440 (0.0%) | −229.9 | −227.3 | 36.34 |
| FOS SRX150476 | MCF 10A Breast | 544 / 17544 (3.1%) | 16815 / 175440 (9.6%) | −229.0 | −226.4 | 0.32 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 285 / 17544 (1.6%) | 12350 / 175440 (7.0%) | −228.2 | −225.6 | 0.23 |
| TP53 SRX19538276 | U2OS Bone | 370 / 17544 (2.1%) | 220 / 175440 (0.1%) | −228.0 | −225.4 | 16.82 |
| ERG SRX063921 | K-562 Blood | 1708 / 17544 (9.7%) | 6700 / 175440 (3.8%) | −227.6 | −225.0 | 2.55 |
| SS18 SRX3468047 | Fibroblasts Others | 823 / 17544 (4.7%) | 21043 / 175440 (12.0%) | −227.0 | −224.4 | 0.39 |
| SMARCA2 SRX8119677 | MeT-5A Others | 515 / 17544 (2.9%) | 16206 / 175440 (9.2%) | −224.6 | −222.1 | 0.32 |
| JUNB SRX8488073 | SUM 229PE Breast | 598 / 17544 (3.4%) | 17521 / 175440 (10.0%) | −224.2 | −221.6 | 0.34 |
| GATA3 SRX190194 | SK-N-SH Neural | 778 / 17544 (4.4%) | 20266 / 175440 (11.6%) | −224.0 | −221.4 | 0.38 |
| ESR1 SRX371478 | MCF-7 Breast | 403 / 17544 (2.3%) | 14315 / 175440 (8.2%) | −223.9 | −221.3 | 0.28 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 1431 / 17544 (8.2%) | 5071 / 175440 (2.9%) | −223.7 | −221.1 | 2.82 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 956 / 17544 (5.4%) | 22812 / 175440 (13.0%) | −222.4 | −219.8 | 0.42 |
| MECOM SRX23677890 | HNT-34 Blood | 2021 / 17544 (11.5%) | 8852 / 175440 (5.0%) | −220.9 | −218.3 | 2.28 |
| TP53 SRX19538275 | U2OS Bone | 349 / 17544 (2.0%) | 197 / 175440 (0.1%) | −219.2 | −216.6 | 17.72 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 372 / 17544 (2.1%) | 254 / 175440 (0.1%) | −217.1 | −214.6 | 14.65 |
| KMT2A SRX2323891 | 293 Kidney | 1129 / 17544 (6.4%) | 3452 / 175440 (2.0%) | −216.5 | −214.0 | 3.27 |
| MECOM SRX23677891 | HNT-34 Blood | 2004 / 17544 (11.4%) | 8849 / 175440 (5.0%) | −215.4 | −212.9 | 2.26 |
| TET2 SRX1427029 | 293 Kidney | 1473 / 17544 (8.4%) | 5455 / 175440 (3.1%) | −214.7 | −212.2 | 2.70 |
| EP300 SRX2671813 | Fibroblasts Others | 237 / 17544 (1.4%) | 11002 / 175440 (6.3%) | −213.2 | −210.7 | 0.22 |
| TCF12 SRX190356 | SK-N-SH Neural | 931 / 17544 (5.3%) | 22102 / 175440 (12.6%) | −212.9 | −210.4 | 0.42 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1848 / 17544 (10.5%) | 7866 / 175440 (4.5%) | −212.6 | −210.1 | 2.35 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1140 / 17544 (6.5%) | 24974 / 175440 (14.2%) | −211.3 | −208.7 | 0.46 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 229 / 17544 (1.3%) | 10773 / 175440 (6.1%) | −210.5 | −208.0 | 0.21 |
| JUNB SRX8488088 | SUM 229PE Breast | 647 / 17544 (3.7%) | 17807 / 175440 (10.1%) | −210.3 | −207.8 | 0.36 |
| GRHL3 SRX2582162 | NHEK Epidermis | 1208 / 17544 (6.9%) | 3968 / 175440 (2.3%) | −210.3 | −207.8 | 3.04 |
| BRD1 SRX286203 | RKO Digestive tract | 1277 / 17544 (7.3%) | 4371 / 175440 (2.5%) | −209.7 | −207.2 | 2.92 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 277 / 17544 (1.6%) | 11649 / 175440 (6.6%) | −209.7 | −207.2 | 0.24 |
| TP53 SRX19538267 | U2OS Bone | 331 / 17544 (1.9%) | 183 / 175440 (0.1%) | −209.4 | −207.0 | 18.09 |
| FOS SRX4192879 | MCF 10A Breast | 366 / 17544 (2.1%) | 13213 / 175440 (7.5%) | −208.9 | −206.4 | 0.28 |
| ZFX SRX7805372 | 293 Kidney | 1726 / 17544 (9.8%) | 7143 / 175440 (4.1%) | −208.8 | −206.3 | 2.42 |
| SMARCA4 SRX5212362 | Mel270 Others | 577 / 17544 (3.3%) | 16636 / 175440 (9.5%) | −207.9 | −205.4 | 0.35 |
| TP53 SRX19538280 | Osteoblasts Bone | 357 / 17544 (2.0%) | 246 / 175440 (0.1%) | −207.6 | −205.1 | 14.51 |
| TP53 SRX19538273 | U2OS Bone | 329 / 17544 (1.9%) | 184 / 175440 (0.1%) | −207.3 | −204.9 | 17.88 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 659 / 17544 (3.8%) | 17877 / 175440 (10.2%) | −207.2 | −204.7 | 0.37 |
| BRPF3 SRX796085 | RKO Digestive tract | 1166 / 17544 (6.6%) | 3773 / 175440 (2.2%) | −207.1 | −204.7 | 3.09 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 411 / 17544 (2.3%) | 13902 / 175440 (7.9%) | −206.6 | −204.1 | 0.30 |
| JUNB SRX10119386 | MCF 10A Breast | 271 / 17544 (1.5%) | 11435 / 175440 (6.5%) | −206.3 | −203.8 | 0.24 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 583 / 17544 (3.3%) | 965 / 175440 (0.6%) | −206.1 | −203.6 | 6.04 |
| FOXA1 SRX176862 | MCF-7 Breast | 440 / 17544 (2.5%) | 14368 / 175440 (8.2%) | −206.1 | −203.6 | 0.31 |
| KAT6A SRX20971022 | Fibroblasts Others | 276 / 17544 (1.6%) | 88 / 175440 (0.1%) | −205.7 | −203.3 | 31.36 |
| ESR1 SRX7624157 | MCF-7 Breast | 902 / 17544 (5.1%) | 21394 / 175440 (12.2%) | −205.2 | −202.7 | 0.42 |
| KAT7 SRX101303 | RKO Digestive tract | 1432 / 17544 (8.2%) | 5358 / 175440 (3.1%) | −205.2 | −202.7 | 2.67 |
| BRPF3 SRX796084 | RKO Digestive tract | 1595 / 17544 (9.1%) | 6399 / 175440 (3.6%) | −203.5 | −201.0 | 2.49 |
| BRPF3 SRX796086 | RKO Digestive tract | 1541 / 17544 (8.8%) | 6073 / 175440 (3.5%) | −202.5 | −200.1 | 2.54 |
| AR SRX1067071 | LHSAR Prostate | 687 / 17544 (3.9%) | 18136 / 175440 (10.3%) | −202.4 | −200.0 | 0.38 |
| ESR1 SRX371479 | MCF-7 Breast | 304 / 17544 (1.7%) | 11905 / 175440 (6.8%) | −202.0 | −199.6 | 0.26 |
| JUN SRX6582171 | GM07492 Others | 667 / 17544 (3.8%) | 17805 / 175440 (10.1%) | −201.6 | −199.1 | 0.37 |
| SMARCA4 SRX5212357 | Mel270 Others | 486 / 17544 (2.8%) | 14972 / 175440 (8.5%) | −201.5 | −199.1 | 0.32 |
| ESR1 SRX7624156 | MCF-7 Breast | 554 / 17544 (3.2%) | 16056 / 175440 (9.2%) | −201.5 | −199.1 | 0.35 |
| ESR1 SRX371469 | MCF-7 Breast | 347 / 17544 (2.0%) | 12647 / 175440 (7.2%) | −201.4 | −199.0 | 0.27 |
| SREBF2 SRX5359049 | HCC70 Breast | 1338 / 17544 (7.6%) | 4859 / 175440 (2.8%) | −200.7 | −198.3 | 2.75 |
| SMARCA4 SRX5212371 | Mel270 Others | 477 / 17544 (2.7%) | 14777 / 175440 (8.4%) | −200.0 | −197.6 | 0.32 |
| JUNB SRX8488074 | SUM 229PE Breast | 443 / 17544 (2.5%) | 14222 / 175440 (8.1%) | −199.9 | −197.5 | 0.31 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 679 / 17544 (3.9%) | 17910 / 175440 (10.2%) | −199.5 | −197.1 | 0.38 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 474 / 17544 (2.7%) | 14687 / 175440 (8.4%) | −198.8 | −196.4 | 0.32 |
| GATA3 SRX190239 | MCF-7 Breast | 507 / 17544 (2.9%) | 15209 / 175440 (8.7%) | −198.5 | −196.1 | 0.33 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 399 / 17544 (2.3%) | 13428 / 175440 (7.7%) | −198.0 | −195.6 | 0.30 |
| SMARCA4 SRX5212366 | Mel270 Others | 458 / 17544 (2.6%) | 14401 / 175440 (8.2%) | −198.0 | −195.6 | 0.32 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 675 / 17544 (3.8%) | 17754 / 175440 (10.1%) | −196.8 | −194.5 | 0.38 |
| JUN SRX883584 | MDA-MB-231 Breast | 537 / 17544 (3.1%) | 15627 / 175440 (8.9%) | −196.8 | −194.4 | 0.34 |
| TP53 SRX19538281 | Osteoblasts Bone | 379 / 17544 (2.2%) | 336 / 175440 (0.2%) | −196.8 | −194.4 | 11.28 |
| TET2 SRX2014505 | Jurkat Blood | 2804 / 17544 (16.0%) | 15019 / 175440 (8.6%) | −196.2 | −193.8 | 1.87 |
| Epitope tags SRX2867680 | 293 Kidney | 2227 / 17544 (12.7%) | 10802 / 175440 (6.2%) | −196.1 | −193.7 | 2.06 |
| CHD6 SRX17709200 | C4-2 Prostate | 1711 / 17544 (9.8%) | 7288 / 175440 (4.2%) | −195.7 | −193.3 | 2.35 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 406 / 17544 (2.3%) | 13466 / 175440 (7.7%) | −195.7 | −193.3 | 0.30 |
| JUNB SRX4192882 | MCF 10A Breast | 243 / 17544 (1.4%) | 10599 / 175440 (6.0%) | −195.6 | −193.3 | 0.23 |
| FOXA1 SRX4815197 | MCF-7 Breast | 860 / 17544 (4.9%) | 20422 / 175440 (11.6%) | −195.3 | −193.0 | 0.42 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 446 / 17544 (2.5%) | 14107 / 175440 (8.0%) | −195.1 | −192.7 | 0.32 |
| JUN SRX4192884 | MCF 10A Breast | 263 / 17544 (1.5%) | 10940 / 175440 (6.2%) | −194.6 | −192.3 | 0.24 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 841 / 17544 (4.8%) | 20106 / 175440 (11.5%) | −194.2 | −191.9 | 0.42 |
| GATA3 SRX176864 | MCF-7 Breast | 231 / 17544 (1.3%) | 10323 / 175440 (5.9%) | −194.0 | −191.7 | 0.22 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 456 / 17544 (2.6%) | 14221 / 175440 (8.1%) | −193.5 | −191.2 | 0.32 |
| FOXA1 SRX176863 | MCF-7 Breast | 424 / 17544 (2.4%) | 13682 / 175440 (7.8%) | −193.2 | −190.8 | 0.31 |
| ESR1 SRX4367193 | MCF-7 Breast | 1168 / 17544 (6.7%) | 24636 / 175440 (14.0%) | −193.1 | −190.8 | 0.47 |
| IRF3 SRX11453861 | Hep G2 Liver | 260 / 17544 (1.5%) | 85 / 175440 (0.0%) | −192.6 | −190.3 | 30.59 |
| ESR1 SRX176860 | MCF-7 Breast | 591 / 17544 (3.4%) | 16305 / 175440 (9.3%) | −192.0 | −189.7 | 0.36 |
| TP53 SRX19538269 | U2OS Bone | 420 / 17544 (2.4%) | 473 / 175440 (0.3%) | −191.9 | −189.6 | 8.88 |
| FOXA1 SRX1161177 | MCF-7 Breast | 353 / 17544 (2.0%) | 12446 / 175440 (7.1%) | −191.8 | −189.4 | 0.28 |
| VGLL1 SRX24602130 | BT-20 Breast | 348 / 17544 (2.0%) | 12331 / 175440 (7.0%) | −190.9 | −188.6 | 0.28 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 340 / 17544 (1.9%) | 12189 / 175440 (6.9%) | −190.8 | −188.5 | 0.28 |
| JUN SRX6582172 | Fibroblasts Others | 463 / 17544 (2.6%) | 14213 / 175440 (8.1%) | −189.9 | −187.6 | 0.33 |
| PRRX1 SRX15235713 | Hs 578T Breast | 414 / 17544 (2.4%) | 13400 / 175440 (7.6%) | −189.5 | −187.2 | 0.31 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 617 / 17544 (3.5%) | 16609 / 175440 (9.5%) | −189.3 | −187.0 | 0.37 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 748 / 17544 (4.3%) | 1798 / 175440 (1.0%) | −189.2 | −186.9 | 4.16 |
| FOSL2 SRX190296 | SK-N-SH Neural | 470 / 17544 (2.7%) | 14295 / 175440 (8.1%) | −189.0 | −186.7 | 0.33 |
| PHF6 SRX11508321 | G-401 Kidney | 1664 / 17544 (9.5%) | 7110 / 175440 (4.1%) | −188.8 | −186.5 | 2.34 |
| MethylCap SRX014767 | NB-4 Blood | 1841 / 17544 (10.5%) | 8297 / 175440 (4.7%) | −188.5 | −186.2 | 2.22 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 1690 / 17544 (9.6%) | 7294 / 175440 (4.2%) | −188.2 | −185.9 | 2.32 |
| ESR1 SRX371476 | MCF-7 Breast | 250 / 17544 (1.4%) | 10504 / 175440 (6.0%) | −188.1 | −185.8 | 0.24 |
| YAP1 SRX5718140 | 293 Kidney | 610 / 17544 (3.5%) | 16454 / 175440 (9.4%) | −188.0 | −185.7 | 0.37 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 890 / 17544 (5.1%) | 20537 / 175440 (11.7%) | −187.1 | −184.8 | 0.43 |
| TLE3 SRX4815191 | MCF-7 Breast | 341 / 17544 (1.9%) | 12079 / 175440 (6.9%) | −186.8 | −184.5 | 0.28 |
| MEAF6 DRX234811 | 293 Kidney | 1756 / 17544 (10.0%) | 7761 / 175440 (4.4%) | −186.7 | −184.4 | 2.26 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 495 / 17544 (2.8%) | 751 / 175440 (0.4%) | −186.6 | −184.3 | 6.59 |
| ESR1 SRX20282961 | MCF-7 Breast | 462 / 17544 (2.6%) | 14076 / 175440 (8.0%) | −186.2 | −184.0 | 0.33 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 372 / 17544 (2.1%) | 12568 / 175440 (7.2%) | −185.5 | −183.2 | 0.30 |
| ESR1 SRX1531791 | MCF-7 Breast | 342 / 17544 (1.9%) | 12055 / 175440 (6.9%) | −185.5 | −183.2 | 0.28 |
| AR SRX1067070 | LHSAR Prostate | 906 / 17544 (5.2%) | 20659 / 175440 (11.8%) | −184.4 | −182.1 | 0.44 |
| MYOCD SRX5598318 | A549 Lung | 1824 / 17544 (10.4%) | 8280 / 175440 (4.7%) | −183.8 | −181.5 | 2.20 |
| ATF3 SRX2207918 | CS1AN Epidermis | 2416 / 17544 (13.8%) | 12469 / 175440 (7.1%) | −183.8 | −181.5 | 1.94 |
| FOXA1 SRX3931044 | MCF-7 Breast | 786 / 17544 (4.5%) | 18913 / 175440 (10.8%) | −183.6 | −181.3 | 0.42 |
| JUNB SRX10119383 | MCF 10A Breast | 222 / 17544 (1.3%) | 9846 / 175440 (5.6%) | −183.5 | −181.3 | 0.23 |
| LEO1 SRX1873456 | SEM Blood | 1539 / 17544 (8.8%) | 6398 / 175440 (3.6%) | −183.4 | −181.1 | 2.41 |
| ESR1 SRX20282960 | MCF-7 Breast | 416 / 17544 (2.4%) | 13229 / 175440 (7.5%) | −183.3 | −181.1 | 0.31 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 283 / 17544 (1.6%) | 10948 / 175440 (6.2%) | −183.1 | −180.9 | 0.26 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 964 / 17544 (5.5%) | 2968 / 175440 (1.7%) | −182.5 | −180.2 | 3.25 |
| YAP1 SRX10119364 | MCF 10A Breast | 281 / 17544 (1.6%) | 10889 / 175440 (6.2%) | −182.4 | −180.1 | 0.26 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 656 / 17544 (3.7%) | 1437 / 175440 (0.8%) | −182.0 | −179.8 | 4.57 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 626 / 17544 (3.6%) | 16472 / 175440 (9.4%) | −181.7 | −179.4 | 0.38 |
| MethylCap SRX014766 | NB-4 Blood | 1665 / 17544 (9.5%) | 7261 / 175440 (4.1%) | −181.4 | −179.1 | 2.29 |
| ESR1 SRX176861 | MCF-7 Breast | 611 / 17544 (3.5%) | 16231 / 175440 (9.3%) | −181.3 | −179.1 | 0.38 |
| ESR1 SRX194572 | MCF-7 Breast | 215 / 17544 (1.2%) | 9639 / 175440 (5.5%) | −181.1 | −178.9 | 0.22 |
| TFEB SRX6743819 | iPS cells Pluripotent stem cell | 1570 / 17544 (8.9%) | 6651 / 175440 (3.8%) | −180.6 | −178.4 | 2.36 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 645 / 17544 (3.7%) | 16723 / 175440 (9.5%) | −180.6 | −178.4 | 0.39 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 834 / 17544 (4.8%) | 19486 / 175440 (11.1%) | −180.6 | −178.4 | 0.43 |
| CEBPB SRX150632 | HeLa Uterus | 835 / 17544 (4.8%) | 19500 / 175440 (11.1%) | −180.5 | −178.3 | 0.43 |
| ESR1 SRX371468 | MCF-7 Breast | 220 / 17544 (1.3%) | 9685 / 175440 (5.5%) | −179.4 | −177.2 | 0.23 |
| ESR1 SRX20282939 | MCF-7 Breast | 422 / 17544 (2.4%) | 13192 / 175440 (7.5%) | −179.3 | −177.1 | 0.32 |
| BRD4 SRX736204 | 90-8TL Neural | 953 / 17544 (5.4%) | 2952 / 175440 (1.7%) | −178.9 | −176.7 | 3.23 |
| JUND SRX190357 | SK-N-SH Neural | 463 / 17544 (2.6%) | 13838 / 175440 (7.9%) | −178.9 | −176.7 | 0.33 |
| PHF6 SRX11508322 | G-401 Kidney | 972 / 17544 (5.5%) | 3061 / 175440 (1.7%) | −178.5 | −176.3 | 3.18 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 879 / 17544 (5.0%) | 2564 / 175440 (1.5%) | −178.2 | −176.0 | 3.43 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 640 / 17544 (3.6%) | 16526 / 175440 (9.4%) | −177.4 | −175.2 | 0.39 |
| JUNB SRX8488089 | SUM 229PE Breast | 358 / 17544 (2.0%) | 12063 / 175440 (6.9%) | −177.3 | −175.1 | 0.30 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 530 / 17544 (3.0%) | 14833 / 175440 (8.5%) | −177.0 | −174.8 | 0.36 |
| GATA3 SRX5057632 | MCF-7 Breast | 223 / 17544 (1.3%) | 9653 / 175440 (5.5%) | −176.6 | −174.4 | 0.23 |
| KMT2A SRX2281249 | SEM Blood | 2045 / 17544 (11.7%) | 9983 / 175440 (5.7%) | −176.3 | −174.1 | 2.05 |
| FOXA1 SRX371483 | MCF-7 Breast | 425 / 17544 (2.4%) | 13134 / 175440 (7.5%) | −176.2 | −174.0 | 0.32 |
| Epitope tags SRX7276677 | 293 Kidney | 2787 / 17544 (15.9%) | 15470 / 175440 (8.8%) | −175.9 | −173.7 | 1.80 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1357 / 17544 (7.7%) | 26420 / 175440 (15.1%) | −175.5 | −173.3 | 0.51 |
| FOXA1 SRX371481 | MCF-7 Breast | 402 / 17544 (2.3%) | 12735 / 175440 (7.3%) | −175.4 | −173.2 | 0.32 |
| JUNB SRX10119384 | MCF 10A Breast | 199 / 17544 (1.1%) | 9160 / 175440 (5.2%) | −175.3 | −173.1 | 0.22 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 1093 / 17544 (6.2%) | 22874 / 175440 (13.0%) | −174.9 | −172.7 | 0.48 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 476 / 17544 (2.7%) | 13907 / 175440 (7.9%) | −174.8 | −172.6 | 0.34 |
| FOXA1 SRX1161173 | MCF-7 Breast | 292 / 17544 (1.7%) | 10841 / 175440 (6.2%) | −174.5 | −172.3 | 0.27 |
| ZFX SRX7805370 | 293 Kidney | 1231 / 17544 (7.0%) | 4629 / 175440 (2.6%) | −173.7 | −171.5 | 2.66 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 499 / 17544 (2.8%) | 14233 / 175440 (8.1%) | −173.7 | −171.5 | 0.35 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 496 / 17544 (2.8%) | 14177 / 175440 (8.1%) | −173.4 | −171.2 | 0.35 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 821 / 17544 (4.7%) | 19021 / 175440 (10.8%) | −173.2 | −171.1 | 0.43 |
| CHD6 SRX17709201 | C4-2 Prostate | 1606 / 17544 (9.2%) | 7034 / 175440 (4.0%) | −173.0 | −170.8 | 2.28 |
| RAC1 SRX10365541 | MCF-7 Breast | 180 / 17544 (1.0%) | 8728 / 175440 (5.0%) | −173.0 | −170.8 | 0.21 |
| JUN SRX7277180 | GM07492 Others | 294 / 17544 (1.7%) | 10823 / 175440 (6.2%) | −172.8 | −170.6 | 0.27 |
| Epitope tags SRX10715360 | HCB1 Blood | 1195 / 17544 (6.8%) | 4436 / 175440 (2.5%) | −172.3 | −170.1 | 2.69 |
| FOXA1 SRX371482 | MCF-7 Breast | 555 / 17544 (3.2%) | 15051 / 175440 (8.6%) | −172.2 | −170.0 | 0.37 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 261 / 17544 (1.5%) | 128 / 175440 (0.1%) | −172.1 | −169.9 | 20.39 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 264 / 17544 (1.5%) | 10259 / 175440 (5.8%) | −171.9 | −169.7 | 0.26 |
| FOS SRX3322636 | MCF-7 Breast | 226 / 17544 (1.3%) | 9568 / 175440 (5.5%) | −171.8 | −169.7 | 0.24 |
| ESR1 SRX194569 | MCF-7 Breast | 395 / 17544 (2.3%) | 12492 / 175440 (7.1%) | −171.6 | −169.4 | 0.32 |
| PBX3 SRX190343 | SK-N-SH Neural | 791 / 17544 (4.5%) | 18522 / 175440 (10.6%) | −171.6 | −169.4 | 0.43 |
| ESR1 SRX371467 | MCF-7 Breast | 398 / 17544 (2.3%) | 12521 / 175440 (7.1%) | −171.0 | −168.8 | 0.32 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 790 / 17544 (4.5%) | 2184 / 175440 (1.2%) | −170.8 | −168.7 | 3.62 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 344 / 17544 (2.0%) | 11614 / 175440 (6.6%) | −170.8 | −168.7 | 0.30 |
| AR SRX10820653 | LNCAP Prostate | 303 / 17544 (1.7%) | 225 / 175440 (0.1%) | −170.7 | −168.6 | 13.47 |
| ESR1 SRX371470 | ZR-75-1 Breast | 348 / 17544 (2.0%) | 11675 / 175440 (6.7%) | −170.5 | −168.4 | 0.30 |
| EP300 SRX150579 | HeLa Uterus | 228 / 17544 (1.3%) | 9560 / 175440 (5.4%) | −170.5 | −168.3 | 0.24 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 240 / 17544 (1.4%) | 9780 / 175440 (5.6%) | −170.4 | −168.2 | 0.25 |
| ESR1 SRX371471 | ZR-75-1 Breast | 418 / 17544 (2.4%) | 12816 / 175440 (7.3%) | −170.1 | −168.0 | 0.33 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 956 / 17544 (5.4%) | 20792 / 175440 (11.9%) | −170.0 | −167.9 | 0.46 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 703 / 17544 (4.0%) | 17157 / 175440 (9.8%) | −169.3 | −167.1 | 0.41 |
| GRHL3 SRX2582161 | NHEK Epidermis | 969 / 17544 (5.5%) | 3169 / 175440 (1.8%) | −168.8 | −166.6 | 3.06 |
| NKX2-1 SRX2164786 | A549 Lung | 622 / 17544 (3.5%) | 15940 / 175440 (9.1%) | −168.7 | −166.6 | 0.39 |
| SUZ12 SRX10184494 | K-562 Blood | 2585 / 17544 (14.7%) | 14144 / 175440 (8.1%) | −168.7 | −166.6 | 1.83 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 332 / 17544 (1.9%) | 11333 / 175440 (6.5%) | −168.3 | −166.2 | 0.29 |
| CXXC1 SRX1424886 | SEM Blood | 1515 / 17544 (8.6%) | 6527 / 175440 (3.7%) | −168.3 | −166.2 | 2.32 |
| FOXA1 SRX1161175 | MCF-7 Breast | 281 / 17544 (1.6%) | 10444 / 175440 (6.0%) | −168.2 | −166.0 | 0.27 |
| FOXA1 SRX1161176 | MCF-7 Breast | 368 / 17544 (2.1%) | 11929 / 175440 (6.8%) | −168.0 | −165.9 | 0.31 |
| ESR1 SRX371477 | MCF-7 Breast | 171 / 17544 (1.0%) | 8400 / 175440 (4.8%) | −167.9 | −165.8 | 0.20 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 566 / 17544 (3.2%) | 15061 / 175440 (8.6%) | −167.8 | −165.7 | 0.38 |
| FOXA1 SRX1787653 | MCF-7 Breast | 302 / 17544 (1.7%) | 10773 / 175440 (6.1%) | −167.0 | −164.8 | 0.28 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 661 / 17544 (3.8%) | 16430 / 175440 (9.4%) | −166.2 | −164.1 | 0.40 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 342 / 17544 (1.9%) | 11430 / 175440 (6.5%) | −166.2 | −164.0 | 0.30 |
| FOS SRX070879 | HUVEC Cardiovascular | 399 / 17544 (2.3%) | 12373 / 175440 (7.1%) | −166.1 | −164.0 | 0.32 |
| MEAF6 DRX300417 | 293 Kidney | 1570 / 17544 (8.9%) | 6950 / 175440 (4.0%) | −165.3 | −163.2 | 2.26 |
| ESR1 SRX10365536 | MCF-7 Breast | 192 / 17544 (1.1%) | 8730 / 175440 (5.0%) | −165.2 | −163.1 | 0.22 |
| DOT1L SRX10606582 | GIST-T1 Digestive tract | 1755 / 17544 (10.0%) | 8213 / 175440 (4.7%) | −165.1 | −163.0 | 2.14 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 806 / 17544 (4.6%) | 2341 / 175440 (1.3%) | −164.1 | −162.0 | 3.44 |
| ARID1A SRX5679787 | 12Z Others | 127 / 17544 (0.7%) | 7398 / 175440 (4.2%) | −164.1 | −162.0 | 0.17 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1491 / 17544 (8.5%) | 27647 / 175440 (15.8%) | −164.0 | −161.9 | 0.54 |
| TEAD1 SRX3401272 | MCF-7 Breast | 280 / 17544 (1.6%) | 10288 / 175440 (5.9%) | −163.7 | −161.6 | 0.27 |
| ESR1 SRX20282972 | MCF-7 Breast | 437 / 17544 (2.5%) | 12896 / 175440 (7.4%) | −163.5 | −161.4 | 0.34 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 362 / 17544 (2.1%) | 11672 / 175440 (6.7%) | −163.4 | −161.3 | 0.31 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 584 / 17544 (3.3%) | 15160 / 175440 (8.6%) | −163.0 | −160.9 | 0.39 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 607 / 17544 (3.5%) | 15493 / 175440 (8.8%) | −162.8 | −160.7 | 0.39 |
| FOXA1 SRX371480 | MCF-7 Breast | 262 / 17544 (1.5%) | 9939 / 175440 (5.7%) | −162.7 | −160.6 | 0.26 |
| ING5 SRX286202 | RKO Digestive tract | 1335 / 17544 (7.6%) | 5472 / 175440 (3.1%) | −162.4 | −160.3 | 2.44 |
| RAC1 SRX10365543 | MCF-7 Breast | 199 / 17544 (1.1%) | 8765 / 175440 (5.0%) | −162.0 | −159.9 | 0.23 |
| HEXIM1 SRX1177905 | HCT 116 Digestive tract | 1892 / 17544 (10.8%) | 9243 / 175440 (5.3%) | −161.8 | −159.8 | 2.05 |
| JUND SRX150408 | HeLa Uterus | 328 / 17544 (1.9%) | 11043 / 175440 (6.3%) | −161.6 | −159.5 | 0.30 |
| FOSL2 SRX190204 | A549 Lung | 383 / 17544 (2.2%) | 11944 / 175440 (6.8%) | −161.2 | −159.1 | 0.32 |
| ARID1A SRX5089376 | MCF-7 Breast | 336 / 17544 (1.9%) | 11150 / 175440 (6.4%) | −160.6 | −158.5 | 0.30 |
| ESR1 SRX20282954 | MCF-7 Breast | 434 / 17544 (2.5%) | 12752 / 175440 (7.3%) | −160.6 | −158.5 | 0.34 |
| TP53 SRX19538270 | U2OS Bone | 374 / 17544 (2.1%) | 467 / 175440 (0.3%) | −160.6 | −158.5 | 8.01 |
| YAP1 SRX1038945 | IMR-90 Lung | 282 / 17544 (1.6%) | 10204 / 175440 (5.8%) | −160.0 | −157.9 | 0.28 |
| MCM3 SRX9107920 | hTERT RPE-1 Neural | 958 / 17544 (5.5%) | 3228 / 175440 (1.8%) | −159.7 | −157.6 | 2.97 |
| TEAD1 SRX716558 | SF268 Neural | 178 / 17544 (1.0%) | 8293 / 175440 (4.7%) | −159.7 | −157.6 | 0.21 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 388 / 17544 (2.2%) | 11966 / 175440 (6.8%) | −159.4 | −157.4 | 0.32 |
| STAT3 SRX150630 | MCF 10A Breast | 355 / 17544 (2.0%) | 11393 / 175440 (6.5%) | −158.5 | −156.4 | 0.31 |
| STAT3 SRX150479 | MCF 10A Breast | 359 / 17544 (2.0%) | 11446 / 175440 (6.5%) | −158.1 | −156.1 | 0.31 |
| ARID1A SRX5679788 | 12Z Others | 149 / 17544 (0.8%) | 7641 / 175440 (4.4%) | −156.9 | −154.8 | 0.20 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 345 / 17544 (2.0%) | 11171 / 175440 (6.4%) | −156.7 | −154.7 | 0.31 |
| KAT6A DRX366108 | 293 Kidney | 1754 / 17544 (10.0%) | 8398 / 175440 (4.8%) | −156.6 | −154.6 | 2.09 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 612 / 17544 (3.5%) | 15304 / 175440 (8.7%) | −155.6 | −153.6 | 0.40 |
| Epitope tags SRX2255894 | 293 Kidney | 1386 / 17544 (7.9%) | 5929 / 175440 (3.4%) | −155.6 | −153.5 | 2.34 |
| AR SRX1067067 | LHSAR Prostate | 686 / 17544 (3.9%) | 16376 / 175440 (9.3%) | −155.2 | −153.1 | 0.42 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 623 / 17544 (3.6%) | 1517 / 175440 (0.9%) | −155.2 | −153.1 | 4.11 |
| JUND SRX699738 | HCASMC Cardiovascular | 559 / 17544 (3.2%) | 14483 / 175440 (8.3%) | −154.9 | −152.8 | 0.39 |
| ESR1 SRX2943591 | MCF-7 Breast | 275 / 17544 (1.6%) | 9913 / 175440 (5.7%) | −154.8 | −152.7 | 0.28 |
| TP53 SRX19538282 | Osteoblasts Bone | 327 / 17544 (1.9%) | 347 / 175440 (0.2%) | −154.6 | −152.5 | 9.42 |
| FOS SRX150664 | HUVEC Cardiovascular | 531 / 17544 (3.0%) | 14040 / 175440 (8.0%) | −154.4 | −152.3 | 0.38 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 303 / 17544 (1.7%) | 10382 / 175440 (5.9%) | −154.3 | −152.2 | 0.29 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 287 / 17544 (1.6%) | 10101 / 175440 (5.8%) | −154.1 | −152.1 | 0.28 |
| FOXA1 SRX1161174 | MCF-7 Breast | 417 / 17544 (2.4%) | 12245 / 175440 (7.0%) | −153.9 | −151.9 | 0.34 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 523 / 17544 (3.0%) | 13899 / 175440 (7.9%) | −153.9 | −151.9 | 0.38 |
| DAXX SRX1021630 | PC-3 Prostate | 399 / 17544 (2.3%) | 11950 / 175440 (6.8%) | −153.7 | −151.6 | 0.33 |
| ESR1 SRX10365532 | MCF-7 Breast | 208 / 17544 (1.2%) | 8680 / 175440 (4.9%) | −153.6 | −151.6 | 0.24 |
| Epitope tags SRX15725652 | 293 Kidney | 1869 / 17544 (10.7%) | 9279 / 175440 (5.3%) | −153.6 | −151.5 | 2.01 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 374 / 17544 (2.1%) | 11539 / 175440 (6.6%) | −153.6 | −151.5 | 0.32 |
| FOSL1 SRX2585779 | MDA-MB-231 Breast | 184 / 17544 (1.0%) | 8224 / 175440 (4.7%) | −153.5 | −151.4 | 0.22 |
| WWTR1 SRX10119367 | MCF 10A Breast | 467 / 17544 (2.7%) | 13007 / 175440 (7.4%) | −153.2 | −151.1 | 0.36 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 659 / 17544 (3.8%) | 15895 / 175440 (9.1%) | −153.0 | −151.0 | 0.41 |
| WAS SRX5371250 | GM11518 Blood | 1133 / 17544 (6.5%) | 4369 / 175440 (2.5%) | −153.0 | −150.9 | 2.59 |
| Epitope tags DRX443510 | 293 Kidney | 1451 / 17544 (8.3%) | 6411 / 175440 (3.7%) | −152.8 | −150.7 | 2.26 |
| STAT5B SRX831881 | CD8+ T cells Blood | 249 / 17544 (1.4%) | 152 / 175440 (0.1%) | −152.0 | −150.0 | 16.38 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 343 / 17544 (2.0%) | 10972 / 175440 (6.3%) | −151.8 | −149.7 | 0.31 |
| YAP1 SRX10119387 | MDA-MB-231 Breast | 285 / 17544 (1.6%) | 9983 / 175440 (5.7%) | −151.5 | −149.5 | 0.29 |
| Epitope tags SRX15725650 | 293 Kidney | 1667 / 17544 (9.5%) | 7911 / 175440 (4.5%) | −151.5 | −149.5 | 2.11 |
| FOXL2 SRX6957431 | KGN Gonad | 927 / 17544 (5.3%) | 19629 / 175440 (11.2%) | −151.4 | −149.4 | 0.47 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 189 / 17544 (1.1%) | 8240 / 175440 (4.7%) | −150.9 | −148.9 | 0.23 |
| JUN SRX2355072 | HAEC Cardiovascular | 533 / 17544 (3.0%) | 13923 / 175440 (7.9%) | −150.4 | −148.4 | 0.38 |
| BRD4 SRX23813262 | C4-2B Prostate | 1570 / 17544 (8.9%) | 7287 / 175440 (4.2%) | −149.4 | −147.4 | 2.15 |
| Epitope tags SRX10549778 | K-562 Blood | 1121 / 17544 (6.4%) | 4355 / 175440 (2.5%) | −149.3 | −147.3 | 2.57 |
| ESR1 SRX10365535 | MCF-7 Breast | 328 / 17544 (1.9%) | 10635 / 175440 (6.1%) | −149.2 | −147.1 | 0.31 |
| NR3C1 SRX2609659 | HASM2 Lung | 485 / 17544 (2.8%) | 13143 / 175440 (7.5%) | −149.2 | −147.1 | 0.37 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 297 / 17544 (1.7%) | 10106 / 175440 (5.8%) | −148.9 | −146.9 | 0.29 |
| KAT6A DRX366109 | 293 Kidney | 2076 / 17544 (11.8%) | 10905 / 175440 (6.2%) | −148.8 | −146.8 | 1.90 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 255 / 17544 (1.5%) | 9371 / 175440 (5.3%) | −148.8 | −146.7 | 0.27 |
| ARID1A SRX5089379 | MCF-7 Breast | 410 / 17544 (2.3%) | 11949 / 175440 (6.8%) | −148.6 | −146.5 | 0.34 |
| JUNB SRX10119385 | MCF 10A Breast | 173 / 17544 (1.0%) | 7865 / 175440 (4.5%) | −148.6 | −146.5 | 0.22 |
| SSRP1 SRX3436567 | HT-1080 Bone | 400 / 17544 (2.3%) | 620 / 175440 (0.4%) | −148.4 | −146.4 | 6.45 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 378 / 17544 (2.2%) | 11414 / 175440 (6.5%) | −148.0 | −146.0 | 0.33 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 590 / 17544 (3.4%) | 14689 / 175440 (8.4%) | −148.0 | −145.9 | 0.40 |
| TP53 SRX396254 | Fibroblasts Others | 876 / 17544 (5.0%) | 2923 / 175440 (1.7%) | −147.9 | −145.9 | 3.00 |
| FOXA1 SRX1787652 | MCF-7 Breast | 242 / 17544 (1.4%) | 9112 / 175440 (5.2%) | −147.8 | −145.8 | 0.27 |
| BCOR SRX10184493 | K-562 Blood | 2178 / 17544 (12.4%) | 11690 / 175440 (6.7%) | −147.8 | −145.7 | 1.86 |
| TET2 SRX2513053 | Jurkat Blood | 2115 / 17544 (12.1%) | 11235 / 175440 (6.4%) | −147.2 | −145.2 | 1.88 |
| Epitope tags SRX2745846 | MCF 10A Breast | 263 / 17544 (1.5%) | 9458 / 175440 (5.4%) | −147.1 | −145.1 | 0.28 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 438 / 17544 (2.5%) | 12337 / 175440 (7.0%) | −147.0 | −145.0 | 0.36 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 754 / 17544 (4.3%) | 17028 / 175440 (9.7%) | −147.0 | −145.0 | 0.44 |
| ESR1 SRX8537722 | MCF-7 Breast | 385 / 17544 (2.2%) | 11489 / 175440 (6.5%) | −146.8 | −144.8 | 0.34 |
| FOXA1 SRX11222441 | MCF-7 Breast | 314 / 17544 (1.8%) | 10321 / 175440 (5.9%) | −146.7 | −144.7 | 0.30 |
| ESR1 SRX330067 | MCF-7 Breast | 374 / 17544 (2.1%) | 11308 / 175440 (6.4%) | −146.7 | −144.7 | 0.33 |
| FOXA1 SRX1787655 | MCF-7 Breast | 196 / 17544 (1.1%) | 8243 / 175440 (4.7%) | −146.6 | −144.6 | 0.24 |
| ESR1 SRX1012632 | MCF-7 Breast | 193 / 17544 (1.1%) | 8186 / 175440 (4.7%) | −146.5 | −144.5 | 0.24 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 440 / 17544 (2.5%) | 12342 / 175440 (7.0%) | −146.3 | −144.3 | 0.36 |
| EP300 SRX2194265 | SUM 159PT Breast | 652 / 17544 (3.7%) | 15535 / 175440 (8.9%) | −146.3 | −144.3 | 0.42 |
| TLE3 SRX4815192 | MCF-7 Breast | 373 / 17544 (2.1%) | 11273 / 175440 (6.4%) | −146.2 | −144.2 | 0.33 |
| ESR1 SRX2881000 | MCF-7 Breast | 365 / 17544 (2.1%) | 11141 / 175440 (6.4%) | −146.1 | −144.1 | 0.33 |
| ESR1 SRX20282955 | MCF-7 Breast | 439 / 17544 (2.5%) | 12320 / 175440 (7.0%) | −146.1 | −144.1 | 0.36 |
| ESR1 SRX4367192 | MCF-7 Breast | 849 / 17544 (4.8%) | 18294 / 175440 (10.4%) | −145.3 | −143.3 | 0.46 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 420 / 17544 (2.4%) | 11990 / 175440 (6.8%) | −145.1 | −143.2 | 0.35 |
| ESR1 SRX330069 | MCF-7 Breast | 249 / 17544 (1.4%) | 9148 / 175440 (5.2%) | −145.0 | −143.0 | 0.27 |
| JUN SRX6582163 | BJ-5ta Epidermis | 526 / 17544 (3.0%) | 13621 / 175440 (7.8%) | −145.0 | −143.0 | 0.39 |
| ESR1 SRX371475 | BT-474 Breast | 207 / 17544 (1.2%) | 8388 / 175440 (4.8%) | −144.8 | −142.8 | 0.25 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 222 / 17544 (1.3%) | 113 / 175440 (0.1%) | −144.7 | −142.7 | 19.65 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 392 / 17544 (2.2%) | 11511 / 175440 (6.6%) | −144.2 | −142.2 | 0.34 |
| ESR1 SRX330070 | MCF-7 Breast | 209 / 17544 (1.2%) | 8401 / 175440 (4.8%) | −144.1 | −142.1 | 0.25 |
| WWTR1 SRX10119390 | MDA-MB-231 Breast | 141 / 17544 (0.8%) | 7110 / 175440 (4.1%) | −144.0 | −142.1 | 0.20 |
| AFF1 SRX2281250 | SEM Blood | 977 / 17544 (5.6%) | 3573 / 175440 (2.0%) | −143.5 | −141.5 | 2.73 |
| ESR1 SRX20282973 | MCF-7 Breast | 510 / 17544 (2.9%) | 13321 / 175440 (7.6%) | −143.5 | −141.5 | 0.38 |
| G3BP1 SRX24196609 | KGN Gonad | 1632 / 17544 (9.3%) | 7849 / 175440 (4.5%) | −143.5 | −141.5 | 2.08 |
| AR SRX10820651 | LNCAP Prostate | 308 / 17544 (1.8%) | 336 / 175440 (0.2%) | −143.4 | −141.4 | 9.17 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 738 / 17544 (4.2%) | 16654 / 175440 (9.5%) | −143.3 | −141.3 | 0.44 |
| NR3C1 SRX2609661 | HASM2 Lung | 472 / 17544 (2.7%) | 12734 / 175440 (7.3%) | −143.3 | −141.3 | 0.37 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 298 / 17544 (1.7%) | 9925 / 175440 (5.7%) | −143.0 | −141.0 | 0.30 |
| ESR1 SRX2881002 | MCF-7 Breast | 400 / 17544 (2.3%) | 11589 / 175440 (6.6%) | −142.8 | −140.8 | 0.35 |
| EP300 SRX1012648 | MCF-7 Breast | 192 / 17544 (1.1%) | 8048 / 175440 (4.6%) | −142.8 | −140.8 | 0.24 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1894 / 17544 (10.8%) | 9737 / 175440 (5.6%) | −142.7 | −140.7 | 1.95 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 596 / 17544 (3.4%) | 14575 / 175440 (8.3%) | −142.7 | −140.7 | 0.41 |
| FOXA1 SRX1787651 | MCF-7 Breast | 231 / 17544 (1.3%) | 8752 / 175440 (5.0%) | −142.6 | −140.6 | 0.26 |
| FOXA1 SRX11222437 | MCF-7 Breast | 299 / 17544 (1.7%) | 9926 / 175440 (5.7%) | −142.5 | −140.6 | 0.30 |
| FOXA1 SRX5203303 | MCF-7 Breast | 131 / 17544 (0.7%) | 6856 / 175440 (3.9%) | −142.3 | −140.3 | 0.19 |
| AR SRX1067066 | LHSAR Prostate | 877 / 17544 (5.0%) | 18543 / 175440 (10.6%) | −141.9 | −140.0 | 0.47 |
| WWTR1 SRX10119378 | MCF 10A Breast | 456 / 17544 (2.6%) | 12429 / 175440 (7.1%) | −141.8 | −139.8 | 0.37 |
| CDK9 SRX20230567 | Ishikawa Uterus | 1761 / 17544 (10.0%) | 8808 / 175440 (5.0%) | −141.5 | −139.6 | 2.00 |
| FOS SRX3322637 | MCF-7 Breast | 222 / 17544 (1.3%) | 8539 / 175440 (4.9%) | −140.9 | −138.9 | 0.26 |
| FOS SRX7760064 | CFPAC-1 Pancreas | 338 / 17544 (1.9%) | 10518 / 175440 (6.0%) | −140.8 | −138.8 | 0.32 |
| FOXA1 SRX5323843 | MCF-7 Breast | 212 / 17544 (1.2%) | 8355 / 175440 (4.8%) | −140.8 | −138.8 | 0.25 |
| EP300 SRX2194266 | SUM 159PT Breast | 733 / 17544 (4.2%) | 16475 / 175440 (9.4%) | −140.6 | −138.7 | 0.44 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 349 / 17544 (2.0%) | 10685 / 175440 (6.1%) | −140.5 | −138.5 | 0.33 |
| KAT6B DRX411443 | 293 Kidney | 2118 / 17544 (12.1%) | 11451 / 175440 (6.5%) | −140.5 | −138.5 | 1.85 |
| DOT1L SRX10606583 | GIST-T1 Digestive tract | 1236 / 17544 (7.0%) | 5247 / 175440 (3.0%) | −140.2 | −138.2 | 2.36 |
| ESR1 SRX20282953 | MCF-7 Breast | 351 / 17544 (2.0%) | 10701 / 175440 (6.1%) | −139.9 | −137.9 | 0.33 |
| FOXA1 SRX028634 | MCF-7 Breast | 206 / 17544 (1.2%) | 8216 / 175440 (4.7%) | −139.8 | −137.9 | 0.25 |
| ESR1 SRX20282946 | MCF-7 Breast | 255 / 17544 (1.5%) | 9086 / 175440 (5.2%) | −139.8 | −137.9 | 0.28 |
| STAT3 SRX150536 | MCF 10A Breast | 478 / 17544 (2.7%) | 12691 / 175440 (7.2%) | −139.7 | −137.8 | 0.38 |
| CNOT3 SRX886388 | Colorectal carcinoma Digestive tract | 1919 / 17544 (10.9%) | 9999 / 175440 (5.7%) | −139.7 | −137.8 | 1.92 |
| TEAD1 SRX1011298 | HuCCT1 Liver | 173 / 17544 (1.0%) | 7598 / 175440 (4.3%) | −139.6 | −137.7 | 0.23 |
| ESR1 SRX3123829 | MCF-7 Breast | 239 / 17544 (1.4%) | 8797 / 175440 (5.0%) | −139.6 | −137.6 | 0.27 |
| NR3C1 SRX2609665 | HASM2 Lung | 478 / 17544 (2.7%) | 12689 / 175440 (7.2%) | −139.6 | −137.6 | 0.38 |
| SMARCA4 SRX5982340 | A549 Lung | 167 / 17544 (1.0%) | 7482 / 175440 (4.3%) | −139.6 | −137.6 | 0.22 |
| MAU2 SRX15710550 | Fibroblasts Others | 705 / 17544 (4.0%) | 16030 / 175440 (9.1%) | −139.5 | −137.5 | 0.44 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 375 / 17544 (2.1%) | 11075 / 175440 (6.3%) | −139.5 | −137.5 | 0.34 |
| FOXA1 SRX3923514 | MCF-7 Breast | 436 / 17544 (2.5%) | 12031 / 175440 (6.9%) | −139.3 | −137.4 | 0.36 |
| GATA3 SRX5457550 | MCF-7 Breast | 487 / 17544 (2.8%) | 12816 / 175440 (7.3%) | −139.3 | −137.3 | 0.38 |
| ESR1 SRX2943589 | MCF-7 Breast | 213 / 17544 (1.2%) | 8323 / 175440 (4.7%) | −139.3 | −137.3 | 0.26 |
| ESR1 SRX10365533 | MCF-7 Breast | 198 / 17544 (1.1%) | 8050 / 175440 (4.6%) | −139.2 | −137.3 | 0.25 |
| NR3C1 SRX2609664 | HASM2 Lung | 601 / 17544 (3.4%) | 14511 / 175440 (8.3%) | −139.0 | −137.1 | 0.41 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 302 / 17544 (1.7%) | 9857 / 175440 (5.6%) | −138.9 | −137.0 | 0.31 |
| EP300 SRX176885 | MCF-7 Breast | 215 / 17544 (1.2%) | 8350 / 175440 (4.8%) | −138.8 | −136.9 | 0.26 |
| NABP2 SRX9523535 | HT-1080 Bone | 1363 / 17544 (7.8%) | 6116 / 175440 (3.5%) | −138.7 | −136.8 | 2.23 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 567 / 17544 (3.2%) | 13997 / 175440 (8.0%) | −138.7 | −136.7 | 0.41 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 206 / 17544 (1.2%) | 8180 / 175440 (4.7%) | −138.7 | −136.7 | 0.25 |
| EP300 SRX1012643 | MCF-7 Breast | 144 / 17544 (0.8%) | 7011 / 175440 (4.0%) | −138.6 | −136.7 | 0.21 |
| ESR1 SRX371474 | BT-474 Breast | 194 / 17544 (1.1%) | 7960 / 175440 (4.5%) | −138.6 | −136.7 | 0.24 |
| ESR1 SRX1469949 | MCF-7 Breast | 240 / 17544 (1.4%) | 8781 / 175440 (5.0%) | −138.5 | −136.6 | 0.27 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 644 / 17544 (3.7%) | 15111 / 175440 (8.6%) | −138.3 | −136.4 | 0.43 |
| FOS SRX7760063 | CFPAC-1 Pancreas | 266 / 17544 (1.5%) | 9225 / 175440 (5.3%) | −138.3 | −136.3 | 0.29 |
| CEBPB SRX190345 | MCF-7 Breast | 329 / 17544 (1.9%) | 10281 / 175440 (5.9%) | −138.2 | −136.3 | 0.32 |
| FOXA2 SRX3230382 | Hep G2 Liver | 586 / 17544 (3.3%) | 14255 / 175440 (8.1%) | −138.2 | −136.3 | 0.41 |
| TLE3 SRX4815194 | SUM 149PT Breast | 325 / 17544 (1.9%) | 10215 / 175440 (5.8%) | −138.1 | −136.2 | 0.32 |
| Epitope tags SRX14024875 | Mesenchymal stem cells Others | 1787 / 17544 (10.2%) | 9087 / 175440 (5.2%) | −138.0 | −136.1 | 1.97 |
| KMT2A SRX1293531 | MV-4-11 Blood | 2493 / 17544 (14.2%) | 14385 / 175440 (8.2%) | −137.9 | −136.0 | 1.73 |
| ESR1 SRX3110725 | MCF-7 Breast | 385 / 17544 (2.2%) | 11180 / 175440 (6.4%) | −137.9 | −136.0 | 0.34 |
| SMARCA4 SRX5982341 | A549 Lung | 121 / 17544 (0.7%) | 6524 / 175440 (3.7%) | −137.8 | −135.9 | 0.19 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 378 / 17544 (2.2%) | 11057 / 175440 (6.3%) | −137.7 | −135.8 | 0.34 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 813 / 17544 (4.6%) | 17478 / 175440 (10.0%) | −137.7 | −135.8 | 0.47 |
| ESR1 SRX10365558 | MCF-7 Breast | 285 / 17544 (1.6%) | 9528 / 175440 (5.4%) | −137.6 | −135.7 | 0.30 |
| INTS3 SRX3640569 | HeLa Uterus | 1254 / 17544 (7.1%) | 5417 / 175440 (3.1%) | −137.5 | −135.6 | 2.31 |
| CHD1 SRX116454 | hESC H1 Pluripotent stem cell | 813 / 17544 (4.6%) | 2710 / 175440 (1.5%) | −137.3 | −135.4 | 3.00 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 349 / 17544 (2.0%) | 10568 / 175440 (6.0%) | −137.1 | −135.2 | 0.33 |
| CREBBP SRX359409 | 293 Kidney | 1572 / 17544 (9.0%) | 7592 / 175440 (4.3%) | −136.8 | −134.8 | 2.07 |
| FOXA1 SRX11222442 | MCF-7 Breast | 289 / 17544 (1.6%) | 9563 / 175440 (5.5%) | −136.6 | −134.7 | 0.30 |
| SMARCA4 SRX8566546 | 786-O Kidney | 1446 / 17544 (8.2%) | 25790 / 175440 (14.7%) | −136.6 | −134.7 | 0.56 |
| Epitope tags SRX3657345 | 293 Kidney | 2318 / 17544 (13.2%) | 13081 / 175440 (7.5%) | −136.6 | −134.7 | 1.77 |
| CBFB SRX265218 | ME-1 Blood | 1456 / 17544 (8.3%) | 6794 / 175440 (3.9%) | −136.5 | −134.6 | 2.14 |
| ESR1 SRX1012629 | MCF-7 Breast | 272 / 17544 (1.6%) | 9271 / 175440 (5.3%) | −136.5 | −134.6 | 0.29 |
| Epitope tags SRX4892334 | 293 Kidney | 2321 / 17544 (13.2%) | 13114 / 175440 (7.5%) | −136.3 | −134.4 | 1.77 |
| NR2F2 SRX190293 | MCF-7 Breast | 464 / 17544 (2.6%) | 12349 / 175440 (7.0%) | −136.2 | −134.3 | 0.38 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 275 / 17544 (1.6%) | 9303 / 175440 (5.3%) | −136.0 | −134.1 | 0.30 |
| NR3C1 SRX10976921 | A549 Lung | 311 / 17544 (1.8%) | 9910 / 175440 (5.6%) | −135.9 | −134.0 | 0.31 |
| ARID1A SRX5089385 | MCF-7 Breast | 324 / 17544 (1.8%) | 10112 / 175440 (5.8%) | −135.7 | −133.8 | 0.32 |
| DNA-RNA hybrid SRX20083261 | SH-SY5Y Neural | 572 / 17544 (3.3%) | 1457 / 175440 (0.8%) | −135.6 | −133.7 | 3.93 |
| SMARCA4 SRX15419260 | 786-O Kidney | 1449 / 17544 (8.3%) | 25779 / 175440 (14.7%) | −135.5 | −133.6 | 0.56 |
| RELA SRX5938177 | FaDu Others | 408 / 17544 (2.3%) | 11456 / 175440 (6.5%) | −135.5 | −133.6 | 0.36 |
| ESR1 SRX1531796 | MCF-7 Breast | 229 / 17544 (1.3%) | 8489 / 175440 (4.8%) | −135.5 | −133.6 | 0.27 |
| NR3C1 SRX17639412 | A549 Lung | 485 / 17544 (2.8%) | 12639 / 175440 (7.2%) | −135.4 | −133.5 | 0.38 |
| ESR1 SRX8537723 | MCF-7 Breast | 351 / 17544 (2.0%) | 10541 / 175440 (6.0%) | −135.3 | −133.4 | 0.33 |
| SMARCA4 SRX5982364 | A549 Lung | 130 / 17544 (0.7%) | 6631 / 175440 (3.8%) | −135.1 | −133.3 | 0.20 |
| FOXA1 SRX3931043 | MCF-7 Breast | 441 / 17544 (2.5%) | 11954 / 175440 (6.8%) | −135.0 | −133.1 | 0.37 |
| JUN SRX6582165 | BJ-5ta Epidermis | 822 / 17544 (4.7%) | 17491 / 175440 (10.0%) | −135.0 | −133.1 | 0.47 |
| NR3C1 SRX19024866 | MCF-7 Breast | 149 / 17544 (0.8%) | 6999 / 175440 (4.0%) | −134.9 | −133.0 | 0.21 |
| KAT6B DRX411444 | 293 Kidney | 2074 / 17544 (11.8%) | 11283 / 175440 (6.4%) | −134.9 | −133.0 | 1.84 |
| Epitope tags SRX4192708 | MDA-MB-231 Breast | 1020 / 17544 (5.8%) | 3976 / 175440 (2.3%) | −134.8 | −132.9 | 2.57 |
| ESR1 SRX20282971 | MCF-7 Breast | 435 / 17544 (2.5%) | 11848 / 175440 (6.8%) | −134.7 | −132.9 | 0.37 |
| KMT2A SRX2281247 | SEM Blood | 1605 / 17544 (9.1%) | 7872 / 175440 (4.5%) | −134.7 | −132.8 | 2.04 |
| EP300 SRX1012644 | MCF-7 Breast | 191 / 17544 (1.1%) | 7780 / 175440 (4.4%) | −134.7 | −132.8 | 0.25 |
| FOXA1 SRX3931054 | MCF-7 Breast | 406 / 17544 (2.3%) | 11392 / 175440 (6.5%) | −134.5 | −132.7 | 0.36 |
| PGR SRX1012655 | MCF-7 Breast | 285 / 17544 (1.6%) | 9414 / 175440 (5.4%) | −134.2 | −132.4 | 0.30 |
| CEBPB SRX2194250 | SUM 159PT Breast | 529 / 17544 (3.0%) | 13258 / 175440 (7.6%) | −134.2 | −132.3 | 0.40 |
| EP300 SRX10976625 | A549 Lung | 257 / 17544 (1.5%) | 8937 / 175440 (5.1%) | −134.2 | −132.3 | 0.29 |
| NR3C1 SRX10977372 | A549 Lung | 257 / 17544 (1.5%) | 8938 / 175440 (5.1%) | −134.2 | −132.3 | 0.29 |
| FOXA1 SRX028635 | MCF-7 Breast | 217 / 17544 (1.2%) | 8227 / 175440 (4.7%) | −133.9 | −132.0 | 0.26 |
| JUN SRX699737 | HCASMC Cardiovascular | 287 / 17544 (1.6%) | 9441 / 175440 (5.4%) | −133.9 | −132.0 | 0.30 |
| ASCL1 SRX8949802 | Unclassified Unclassified | 1745 / 17544 (9.9%) | 8892 / 175440 (5.1%) | −133.8 | −131.9 | 1.96 |
| FOXA1 SRX3931055 | MCF-7 Breast | 369 / 17544 (2.1%) | 10774 / 175440 (6.1%) | −133.8 | −131.9 | 0.34 |
| ESR1 SRX20282940 | MCF-7 Breast | 483 / 17544 (2.8%) | 12545 / 175440 (7.2%) | −133.7 | −131.8 | 0.39 |
| ESR1 SRX2912055 | MCF-7 Breast | 163 / 17544 (0.9%) | 7227 / 175440 (4.1%) | −133.6 | −131.7 | 0.23 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 565 / 17544 (3.2%) | 13762 / 175440 (7.8%) | −133.4 | −131.5 | 0.41 |
| JUN SRX2355073 | HAEC Cardiovascular | 552 / 17544 (3.1%) | 13561 / 175440 (7.7%) | −133.1 | −131.3 | 0.41 |
| FOXA1 SRX100454 | T-47D Breast | 576 / 17544 (3.3%) | 13909 / 175440 (7.9%) | −133.0 | −131.1 | 0.41 |
| NR3C1 SRX2609662 | HASM2 Lung | 530 / 17544 (3.0%) | 13222 / 175440 (7.5%) | −132.9 | −131.0 | 0.40 |
| MITF SRX7368255 | Hermes 3C Epidermis | 1213 / 17544 (6.9%) | 22620 / 175440 (12.9%) | −132.8 | −130.9 | 0.54 |
| HOXC5 SRX2731653 | PC-3 Prostate | 346 / 17544 (2.0%) | 10373 / 175440 (5.9%) | −132.8 | −130.9 | 0.33 |
| DDIT3 SRX11379509 | Liposarcoma, Myxoid Adipocyte | 341 / 17544 (1.9%) | 10285 / 175440 (5.9%) | −132.5 | −130.7 | 0.33 |
| TEAD4 SRX10640860 | SK-MEL-147 Epidermis | 611 / 17544 (3.5%) | 14401 / 175440 (8.2%) | −132.5 | −130.6 | 0.42 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 1055 / 17544 (6.0%) | 4234 / 175440 (2.4%) | −132.5 | −130.6 | 2.49 |
| FOXA1 SRX190181 | A549 Lung | 317 / 17544 (1.8%) | 9874 / 175440 (5.6%) | −132.0 | −130.1 | 0.32 |
| CDK9 SRX20230573 | Ishikawa Uterus | 2135 / 17544 (12.2%) | 11829 / 175440 (6.7%) | −131.9 | −130.1 | 1.80 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 481 / 17544 (2.7%) | 12440 / 175440 (7.1%) | −131.6 | −129.8 | 0.39 |
| BMI1 SRX8726297 | Tumor Others | 1534 / 17544 (8.7%) | 7448 / 175440 (4.2%) | −131.5 | −129.6 | 2.06 |
| TP53 SRX19538271 | U2OS Bone | 536 / 17544 (3.1%) | 1323 / 175440 (0.8%) | −131.4 | −129.6 | 4.05 |
| SMARCA2 SRX5982361 | A549 Lung | 140 / 17544 (0.8%) | 6718 / 175440 (3.8%) | −131.4 | −129.6 | 0.21 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 511 / 17544 (2.9%) | 12878 / 175440 (7.3%) | −131.3 | −129.4 | 0.40 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1364 / 17544 (7.8%) | 6282 / 175440 (3.6%) | −131.3 | −129.4 | 2.17 |
| ESR1 SRX2897217 | Breast cancer cells Breast | 956 / 17544 (5.4%) | 3640 / 175440 (2.1%) | −131.2 | −129.3 | 2.63 |
| CDK9 SRX20230570 | Ishikawa Uterus | 1662 / 17544 (9.5%) | 8365 / 175440 (4.8%) | −131.1 | −129.3 | 1.99 |
| ESR1 SRX330068 | MCF-7 Breast | 208 / 17544 (1.2%) | 7978 / 175440 (4.5%) | −131.1 | −129.2 | 0.26 |
| LARP7 SRX1177904 | HCT 116 Digestive tract | 1112 / 17544 (6.3%) | 4622 / 175440 (2.6%) | −131.0 | −129.1 | 2.41 |
| ING2 SRX286201 | RKO Digestive tract | 1367 / 17544 (7.8%) | 6309 / 175440 (3.6%) | −131.0 | −129.1 | 2.17 |
| ESR1 SRX20282938 | MCF-7 Breast | 358 / 17544 (2.0%) | 10493 / 175440 (6.0%) | −130.8 | −128.9 | 0.34 |
| NR3C1 SRX10977373 | A549 Lung | 243 / 17544 (1.4%) | 8581 / 175440 (4.9%) | −130.7 | −128.8 | 0.28 |
| ESR1 SRX1012630 | MCF-7 Breast | 166 / 17544 (0.9%) | 7191 / 175440 (4.1%) | −130.6 | −128.8 | 0.23 |
| DMC1 SRX663450 | Testis Gonad | 580 / 17544 (3.3%) | 1546 / 175440 (0.9%) | −130.6 | −128.7 | 3.75 |
| Epitope tags SRX10549777 | K-562 Blood | 2365 / 17544 (13.5%) | 13636 / 175440 (7.8%) | −130.5 | −128.7 | 1.73 |
| KDM5B SRX3285611 | MCF-7 Breast | 1214 / 17544 (6.9%) | 5294 / 175440 (3.0%) | −130.5 | −128.6 | 2.29 |
| FOXA1 SRX100506 | Hep G2 Liver | 588 / 17544 (3.4%) | 13983 / 175440 (8.0%) | −130.4 | −128.6 | 0.42 |
| JUN SRX6582164 | BJ-5ta Epidermis | 561 / 17544 (3.2%) | 13584 / 175440 (7.7%) | −130.3 | −128.5 | 0.41 |
| NR3C1 SRX2609666 | HASM2 Lung | 437 / 17544 (2.5%) | 11716 / 175440 (6.7%) | −130.2 | −128.4 | 0.37 |
| CDT1 SRX10644243 | HCT 116 Digestive tract | 1570 / 17544 (8.9%) | 7737 / 175440 (4.4%) | −130.1 | −128.3 | 2.03 |
| FOSL1 SRX17608312 | T24 Others | 171 / 17544 (1.0%) | 7272 / 175440 (4.1%) | −130.1 | −128.2 | 0.24 |
| NR3C1 SRX10977357 | A549 Lung | 284 / 17544 (1.6%) | 9253 / 175440 (5.3%) | −129.8 | −128.0 | 0.31 |
| SUZ12 SRX9281791 | 293 Kidney | 359 / 17544 (2.0%) | 577 / 175440 (0.3%) | −129.6 | −127.8 | 6.22 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 439 / 17544 (2.5%) | 11723 / 175440 (6.7%) | −129.6 | −127.7 | 0.37 |
| WWTR1 SRX10119368 | MCF 10A Breast | 319 / 17544 (1.8%) | 9821 / 175440 (5.6%) | −129.5 | −127.6 | 0.32 |
| ESR1 SRX4451213 | MCF-7 Breast | 452 / 17544 (2.6%) | 11917 / 175440 (6.8%) | −129.4 | −127.6 | 0.38 |
| RUNX1 SRX2963102 | PBMC Blood | 1894 / 17544 (10.8%) | 10099 / 175440 (5.8%) | −129.4 | −127.5 | 1.88 |
| CEBPA SRX2630241 | Hep G2 Liver | 544 / 17544 (3.1%) | 13299 / 175440 (7.6%) | −129.4 | −127.5 | 0.41 |
| Epitope tags SRX8030771 | 293 Kidney | 1580 / 17544 (9.0%) | 7831 / 175440 (4.5%) | −129.1 | −127.3 | 2.02 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 765 / 17544 (4.4%) | 16445 / 175440 (9.4%) | −128.9 | −127.1 | 0.47 |
| FOXA2 SRX100448 | Hep G2 Liver | 494 / 17544 (2.8%) | 12526 / 175440 (7.1%) | −128.8 | −126.9 | 0.39 |
| ZEB1 SRX13298925 | MCF-7 Breast | 274 / 17544 (1.6%) | 9046 / 175440 (5.2%) | −128.7 | −126.9 | 0.30 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 162 / 17544 (0.9%) | 7055 / 175440 (4.0%) | −128.6 | −126.8 | 0.23 |
| CBX7 SRX6370188 | NT2-D1 Pluripotent stem cell | 548 / 17544 (3.1%) | 1408 / 175440 (0.8%) | −128.6 | −126.8 | 3.89 |
| KMT2A SRX2323895 | 293 Kidney | 392 / 17544 (2.2%) | 712 / 175440 (0.4%) | −128.5 | −126.6 | 5.51 |
| FOXA1 SRX5203294 | MCF-7 Breast | 125 / 17544 (0.7%) | 6331 / 175440 (3.6%) | −128.4 | −126.5 | 0.20 |
| JADE3 DRX300415 | 293 Kidney | 1452 / 17544 (8.3%) | 6952 / 175440 (4.0%) | −128.3 | −126.5 | 2.09 |
| VGLL1 SRX18013277 | FULVR Breast | 190 / 17544 (1.1%) | 7561 / 175440 (4.3%) | −128.1 | −126.3 | 0.25 |
| ESR1 SRX1012633 | MCF-7 Breast | 230 / 17544 (1.3%) | 8273 / 175440 (4.7%) | −128.1 | −126.3 | 0.28 |
| ERG SRX063918 | MCF-7 Breast | 1448 / 17544 (8.3%) | 6933 / 175440 (4.0%) | −128.0 | −126.2 | 2.09 |
| YAP1 SRX1038944 | IMR-90 Lung | 174 / 17544 (1.0%) | 7259 / 175440 (4.1%) | −127.9 | −126.1 | 0.24 |
| FOXA1 SRX1447317 | MCF-7 Breast | 295 / 17544 (1.7%) | 9363 / 175440 (5.3%) | −127.6 | −125.8 | 0.32 |
Showing first 500 of 17917 rows.